 Intermittent injection vs patient-controlled analgesia sickle cell crisis pain Comparison patients emergency department purpose study prospective assessment morphine sulfate administration intermittent intravenous IV injections Int-IV patient-controlled analgesia PCA patients emergency department ED sickle cell crisis pain Patients bed rest intravenous hydration Linear analog scale pain intensity verbal pain scale level alertness vital signs minutes time discharge ED Patients Int-IV PCA phase patients Int-IV group morphine sulfate mg IV minutes necessary linear analog scale pain intensity mm patients PCA group morphine sulfate mg bolus mg lockout phase patients Int-IV group morphine sulfate mg IV minutes necessary linear analog scale pain intensity mm patients PCA group morphine sulfate mg bolus mg lockout Data unpaired test general linear modeling Mann-Whitney test test phase patients years Int-IV patients years PCA Treatment groups duration pain amount morphine linear analog scale pain intensity verbal pain scale level alertness vital signs final respiratory rate Int-IV phase patients years Int-IV patients years PCA PCA groups elapsed time onset pain treatment hours Int-IV group hours Treatment groups respect total amount morphine linear analog scale pain intensity verbal pain scale vital signs level alertness PCA group significant reduction length stay ED phase phase ED discharge rate incidence side effects groups low- high-dose regimens PCA safe effective place Int-IV administration morphine ED treatment sickle cell crisis pain